The FDA 503A Bulks List is the list established in federal regulation for certain bulk drug substances that may be used to compound patient-specific medications under section 503A when the substance does not have an applicable United States Pharmacopeia or National Formulary drug-substance monograph and is not a component of an FDA-approved drug
HPLC separates mixture components and produces chromatographic peaks that can be interpreted in relation to retention time, peak area, and separation quality [21] [25]
-Synuclein has been reported to cause dysfunction of mitochondrial complex I in PD which in turn increases levels of ROS and consequently ROS-induced oxidative stress (Winklhofer and Haass 2010)
Evans, et al., Efficacy of a novel formulation of L-Carnitine, creatine, and leucine on lean body mass and functional muscle strength in healthy older adults: a randomized, double-blind placebo-controlled study, Nutr Metab (Lond), Jan 2017, 14:7